KC
Karp Carol D.
Directeur Réglementaire
OtherF
Insider track record
ExecutiveAcross 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Karp Carol D., Directeur Réglementaire. Officer active across 1 company, notably Prothena CORP Public Ltd Co. Aggregated, 11 filings have been published. Activity tracked since 9 September 2021. The latest transaction was disclosed on 4 October 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
5,000 shares@ US$12.155.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-23-001091:0
5,000 shares@ US$12.155.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-23-000853:0
5,000 shares@ US$12.155.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-037712:0
5,000 shares@ US$12.155.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-033193:0
5,000 shares@ US$12.155.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-028869:0
10,000 shares@ US$15.040.025% mcap16.8% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-019301:0
10,000 shares@ US$15.0412.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-019301
10,000 shares@ US$15.040.025% mcap16.8% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-033345:0
10,000 shares@ US$15.0412.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-033345
10,000 shares@ US$15.040.025% mcap16.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-030941:0
10,000 shares@ US$15.0412.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-030941
About Karp Carol D.
Karp Carol D. is the Chief Regulatory Officer at PROTHENA CORP PUBLIC LTD CO. She is responsible for the company's regulatory compliance and managing relationships with regulatory agencies. Carol plays a vital role in developing strategies that ensure the company meets all legal and regulatory requirements. Her expertise in regulation is crucial for the success of PROTHENA.